China Shineway Pharmaceutical Group Limited (HKG: 2877)

China Shineway Pharmaceutical Group Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	4,205	4,517	3,951	3,224	2,656	2,706
Revenue Growth (YoY)	-7.27%	14.32%	22.56%	21.38%	-1.86%	5.28%
Cost of Revenue	1,042	1,122	1,012	813.21	667.86	724.43
Gross Profit	3,162	3,394	2,938	2,410	1,988	1,982
Selling, General & Admin	2,107	2,308	2,098	1,756	1,459	1,402
Research & Development	107.01	110.46	117.45	112.71	99.71	102.72
Operating Expenses	2,218	2,424	2,225	1,876	1,565	1,505
Operating Income	944.66	970.1	713.58	534.37	422.4	476.48
Interest Expense	-5.42	-2.74	-0.63	-1.25	-16.6	-2.66
Interest & Investment Income	170.08	105.51	99.1	104.14	132.66	119.47
Currency Exchange Gain (Loss)	18.67	6.61	-8.52	-2.9	-1.95	8.12
Other Non Operating Income (Expenses)	305.32	163.17	113.37	102.23	85.74	86.15
EBT Excluding Unusual Items	1,433	1,243	916.9	736.58	622.25	687.56
Impairment of Goodwill	-	-	-	-	-56.79	-
Gain (Loss) on Sale of Investments	-	-	-	-	-	-8.65
Gain (Loss) on Sale of Assets	-2.26	-2.39	0.13	-16.47	2.06	-0.14
Asset Writedown	-	-	-	-	-172.81	-36
Other Unusual Items	-	-	-	-	0.32	-
Pretax Income	1,431	1,240	917.03	720.1	395.02	642.77
Income Tax Expense	326.52	270.74	194.25	163.43	99.99	139.62
Earnings From Continuing Operations	1,105	969.51	722.77	556.67	295.03	503.15
Net Income	1,105	969.51	722.77	556.67	295.03	503.15
Net Income to Common	1,105	969.51	722.77	556.67	295.03	503.15
Net Income Growth	25.07%	34.14%	29.84%	88.68%	-41.36%	-0.54%
Shares Outstanding (Basic)	755	755	755	755	757	781
Shares Outstanding (Diluted)	755	755	755	755	757	781
Shares Change (YoY)	-	-	0.03%	-0.21%	-3.10%	-4.51%
EPS (Basic)	1.46	1.28	0.96	0.74	0.39	0.64
EPS (Diluted)	1.46	1.28	0.96	0.74	0.39	0.64
EPS Growth	24.89%	33.78%	29.79%	89.08%	-39.08%	3.28%
Free Cash Flow	1,006	788.31	980.21	609.52	572.54	279.59
Free Cash Flow Per Share	1.33	1.04	1.30	0.81	0.76	0.36
Dividend Per Share	0.540	0.420	0.320	0.390	0.320	0.230
Dividend Growth	28.57%	31.25%	-17.95%	21.88%	39.13%	0%
Gross Margin	75.21%	75.15%	74.38%	74.77%	74.85%	73.23%
Operating Margin	22.47%	21.48%	18.06%	16.58%	15.91%	17.61%
Profit Margin	26.27%	21.47%	18.30%	17.27%	11.11%	18.59%
Free Cash Flow Margin	23.92%	17.45%	24.81%	18.91%	21.56%	10.33%
EBITDA	1,105	1,136	888.23	705.11	621.85	672.71
EBITDA Margin	26.28%	25.15%	22.48%	21.87%	23.42%	24.86%
D&A For EBITDA	160.46	165.89	174.65	170.75	199.45	196.23
EBIT	944.66	970.1	713.58	534.37	422.4	476.48
EBIT Margin	22.47%	21.48%	18.06%	16.58%	15.91%	17.61%
Effective Tax Rate	22.82%	21.83%	21.18%	22.70%	25.31%	21.72%

Source: S&P Capital IQ. Standard template. Financial Sources.